SARS antibody |
70R-20086 |
Fitzgerald |
50 ul |
EUR 522 |
Description: Rabbit polyclonal SARS antibody |
Human IgG antibody Laboratories manufactures the nucleocapsid antibody immunity sars reagents distributed by Genprice. The Nucleocapsid Antibody Immunity Sars reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact SARS Antibody. Other Nucleocapsid products are available in stock. Specificity: Nucleocapsid Category: Antibody Group: Immunity Sars
JBS True Blue |
MiTeGen |
300 µl |
EUR 16 |
Description: JBS True Blue |
SeroFlash SARS-CoV-2 IgM/IgG Antibody Detection Kit |
EpiGentek |
25 tests |
EUR 399.3 |
SeroFlash SARS-CoV-2 IgM/IgG Antibody Detection Kit |
EpiGentek |
25 tests |
EUR 399.3 |
SARS-CoV-2 IgG ELISA Kit |
Biovision |
100 assays |
EUR 903.6 |
SARS Spike Antibody |
Abbexa |
-
EUR 1262.40
-
EUR 1846.80
-
EUR 2064.00
|
|
|
SARS Nucleocapsid Antibody |
Abbexa |
-
EUR 1262.40
-
EUR 1846.80
-
EUR 2364.00
|
|
|
Immunity Sars information
SARS Coronavirus Nucleocapsid (1-422) Protein |
20-abx262159 |
Abbexa |
-
EUR 6373.20
-
EUR 393.60
-
EUR 276.00
|
|
|
Recombinant SARS Coronavirus Nucleocapsid (1-422) |
7-07111 |
CHI Scientific |
5µg |
Ask for price |
Recombinant SARS Coronavirus Nucleocapsid (1-422) |
7-07112 |
CHI Scientific |
20µg |
Ask for price |
Recombinant SARS Coronavirus Nucleocapsid (1-422) |
7-07113 |
CHI Scientific |
1000µg |
Ask for price |
Recombinant (E.Coli) SARS-CoV Nucleocapsid (1-422) |
RP-1416 |
Alpha Diagnostics |
10 ug |
EUR 270 |
SARS-CoV Nucleocapsid Recombinant Protein |
11-173 |
ProSci |
0.1 mg |
EUR 752.1 |
Description: Nucleocapsid (N) protein is the most abundant protein found in coronavirus. CoV N protein is a highly immunogenic phosphoprotein important for viral genome replication and modulation of cell signaling pathways. It was first identified by a research team while they were screening for ADP-ribosylated proteins during coronavirus (CoV) infection (Grunewald M. E., et al. 2017, Virology; 517: 62-68). The array of diverse functional activities accommodated in N protein makes it more than a structural protein but also an interesting target in the development of antiviral therapeutics. Because of the conservation of N protein sequence and its strong immunogenicity, N protein of coronavirus is chosen as a diagnostic tool. |
Human Chimeric SARS-CoV-2 Nucleocapsid Protein Antibody (2019-nCov) |
R20480-100UG |
NSJ Bioreagents |
100ug |
EUR 409 |
Recombinant SARS-CoV Nucleocapsid [GST] (aa 1-49) |
VAng-Wyb8617-inquire |
Creative Biolabs |
inquire |
Ask for price |
Description: SARS-CoV Nucleocapsid (aa 1-49), recombinant protein from E. coli, 1 mg/mL. |
Recombinant SARS-CoV Nucleocapsid [GST] (aa 340-390) |
VAng-Wyb8619-inquire |
Creative Biolabs |
inquire |
Ask for price |
Description: SARS-CoV Nucleocapsid (aa 340-390), recombinant protein from E. coli, 1 mg/mL. |
Recombinant SARS Nucleocapsid Protein (aa 1-422) [His] |
VAng-Lsx0058-inquire |
Creative Biolabs |
inquire |
Ask for price |
Description: SARS Nucleocapsid (aa 1-422) [His], recombinant protein from E. coli. |
Nucleocapsid Protein, Avi-His-tag (SARS-CoV-2) |
100778-1 |
BPS Bioscience |
100 µg |
EUR 335 |
Description: SARS-CoV-2 nucleocapsid protein, also known as COVID-19 nucleocapsid and SARS-CoV-2 N protein, Genbank Accession No.: YP_009724397.2, a.a. 1-419(end), with C-terminal Avi-His-tag, expressed in a HEK293 cell expression system. MW= 48 kDa. This protein runs at a higher M.W. by SDS-PAGE due to glycosylation. |
Nucleocapsid Protein, Avi-His-tag (SARS-CoV-2) |
100778-2 |
BPS Bioscience |
1 mg |
EUR 2730 |
Description: SARS-CoV-2 nucleocapsid protein, also known as COVID-19 nucleocapsid and SARS-CoV-2 N protein, Genbank Accession No.: YP_009724397.2, a.a. 1-419(end), with C-terminal Avi-His-tag, expressed in a HEK293 cell expression system. MW= 48 kDa. This protein runs at a higher M.W. by SDS-PAGE due to glycosylation. |
SARS-CoV-2 (COVID-19) Nucleocapsid Matched Pair |
MPN-0001 |
ProSci |
1 Set |
EUR 1029.3 |
|
Description: Coronavirus disease 2019 (COVID-19), formerly known as 2019-nCoV acute respiratory disease, is an infectious disease caused by SARS-CoV-2, a virus closely related to the SARS virus. The disease is the cause of the 2019–20 coronavirus outbreak (1). SARS-CoV-2 is the seventh member of the enveloped, positive-stranded RNA viruses that are able to infect humans. The SARS-CoV-2 genome, like other coronaviruses, encodes for multiple structural and nonstructural proteins. The structural proteins include spike protein (S), envelope protein (E), membrane glycoprotein (M), nucleocapsid phosphoprotein (N), and the nonstructural proteins include open reading frame 1ab (ORF1ab), ORF3a, ORF6, ORF7a, ORF8, and ORF10 (2). Nucleocapsid (N) protein is the most abundant protein of coronavirus. It is also one of the major structural proteins and is involved in the transcription and replication of viral RNA, packaging of the encapsidated genome into virions (3), and interference with cell cycle processes of host cells (4). Moreover, in many coronaviruses, including SARS-CoV, the N protein has high immunogenic activity and is abundantly expressed during infection (5). It can be detected in various patient samples including nasopharyngeal aspirate, urine, and fecal. Both S and N proteins may be potential antigens for serodiagnosis of COVID-19, just as many diagnostic methods have been developed for diagnosing SARS based on S and/or N proteins (6). |
SARS-CoV-2 (COVID-19) Nucleocapsid Matched Pair |
MPN-0002 |
ProSci |
1 Set |
EUR 1029.3 |
|
Description: Coronavirus disease 2019 (COVID-19), formerly known as 2019-nCoV acute respiratory disease, is an infectious disease caused by SARS-CoV-2, a virus closely related to the SARS virus. The disease is the cause of the 2019–20 coronavirus outbreak (1). SARS-CoV-2 is the seventh member of the enveloped, positive-stranded RNA viruses that are able to infect humans. The SARS-CoV-2 genome, like other coronaviruses, encodes for multiple structural and nonstructural proteins. The structural proteins include spike protein (S), envelope protein (E), membrane glycoprotein (M), nucleocapsid phosphoprotein (N), and the nonstructural proteins include open reading frame 1ab (ORF1ab), ORF3a, ORF6, ORF7a, ORF8, and ORF10 (2). Nucleocapsid (N) protein is the most abundant protein of coronavirus. It is also one of the major structural proteins and is involved in the transcription and replication of viral RNA, packaging of the encapsidated genome into virions (3), and interference with cell cycle processes of host cells (4). Moreover, in many coronaviruses, including SARS-CoV, the N protein has high immunogenic activity and is abundantly expressed during infection (5). It can be detected in various patient samples including nasopharyngeal aspirate, urine, and fecal. Both S and N proteins may be potential antigens for serodiagnosis of COVID-19, just as many diagnostic methods have been developed for diagnosing SARS based on S and/or N proteins (6). |
SARS-CoV-2 (COVID-19) Nucleocapsid Matched Pair |
MPN-0003 |
ProSci |
1 Set |
EUR 1029.3 |
|
Description: Coronavirus disease 2019 (COVID-19), formerly known as 2019-nCoV acute respiratory disease, is an infectious disease caused by SARS-CoV-2, a virus closely related to the SARS virus. The disease is the cause of the 2019–20 coronavirus outbreak (1). SARS-CoV-2 is the seventh member of the enveloped, positive-stranded RNA viruses that are able to infect humans. The SARS-CoV-2 genome, like other coronaviruses, encodes for multiple structural and nonstructural proteins. The structural proteins include spike protein (S), envelope protein (E), membrane glycoprotein (M), nucleocapsid phosphoprotein (N), and the nonstructural proteins include open reading frame 1ab (ORF1ab), ORF3a, ORF6, ORF7a, ORF8, and ORF10 (2). Nucleocapsid (N) protein is the most abundant protein of coronavirus. It is also one of the major structural proteins and is involved in the transcription and replication of viral RNA, packaging of the encapsidated genome into virions (3), and interference with cell cycle processes of host cells (4). Moreover, in many coronaviruses, including SARS-CoV, the N protein has high immunogenic activity and is abundantly expressed during infection (5). It can be detected in various patient samples including nasopharyngeal aspirate, urine, and fecal. Both S and N proteins may be potential antigens for serodiagnosis of COVID-19, just as many diagnostic methods have been developed for diagnosing SARS based on S and/or N proteins (6). |
SARS-CoV-2 (COVID-19) Nucleocapsid Matched Pair |
MPN-0004 |
ProSci |
1 Set |
EUR 1029.3 |
|
Description: Coronavirus disease 2019 (COVID-19), formerly known as 2019-nCoV acute respiratory disease, is an infectious disease caused by SARS-CoV-2, a virus closely related to the SARS virus. The disease is the cause of the 2019–20 coronavirus outbreak (1). SARS-CoV-2 is the seventh member of the enveloped, positive-stranded RNA viruses that are able to infect humans. The SARS-CoV-2 genome, like other coronaviruses, encodes for multiple structural and nonstructural proteins. The structural proteins include spike protein (S), envelope protein (E), membrane glycoprotein (M), nucleocapsid phosphoprotein (N), and the nonstructural proteins include open reading frame 1ab (ORF1ab), ORF3a, ORF6, ORF7a, ORF8, and ORF10 (2). Nucleocapsid (N) protein is the most abundant protein of coronavirus. It is also one of the major structural proteins and is involved in the transcription and replication of viral RNA, packaging of the encapsidated genome into virions (3), and interference with cell cycle processes of host cells (4). Moreover, in many coronaviruses, including SARS-CoV, the N protein has high immunogenic activity and is abundantly expressed during infection (5). It can be detected in various patient samples including nasopharyngeal aspirate, urine, and fecal. Both S and N proteins may be potential antigens for serodiagnosis of COVID-19, just as many diagnostic methods have been developed for diagnosing SARS based on S and/or N proteins (6). |
SARS-CoV-2 (COVID-19) Nucleocapsid Matched Pair |
MPN-0005 |
ProSci |
1 Set |
EUR 1029.3 |
|
Description: Coronavirus disease 2019 (COVID-19), formerly known as 2019-nCoV acute respiratory disease, is an infectious disease caused by SARS-CoV-2, a virus closely related to the SARS virus. The disease is the cause of the 2019–20 coronavirus outbreak (1). SARS-CoV-2 is the seventh member of the enveloped, positive-stranded RNA viruses that are able to infect humans. The SARS-CoV-2 genome, like other coronaviruses, encodes for multiple structural and nonstructural proteins. The structural proteins include spike protein (S), envelope protein (E), membrane glycoprotein (M), nucleocapsid phosphoprotein (N), and the nonstructural proteins include open reading frame 1ab (ORF1ab), ORF3a, ORF6, ORF7a, ORF8, and ORF10 (2). Nucleocapsid (N) protein is the most abundant protein of coronavirus. It is also one of the major structural proteins and is involved in the transcription and replication of viral RNA, packaging of the encapsidated genome into virions (3), and interference with cell cycle processes of host cells (4). Moreover, in many coronaviruses, including SARS-CoV, the N protein has high immunogenic activity and is abundantly expressed during infection (5). It can be detected in various patient samples including nasopharyngeal aspirate, urine, and fecal. Both S and N proteins may be potential antigens for serodiagnosis of COVID-19, just as many diagnostic methods have been developed for diagnosing SARS based on S and/or N proteins (6). |